These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 33170119)

  • 21. Molecular characterization of multidrug-resistant (MDR) Pseudomonas aeruginosa isolated in a burn center.
    de Almeida Silva KCF; Calomino MA; Deutsch G; de Castilho SR; de Paula GR; Esper LMR; Teixeira LA
    Burns; 2017 Feb; 43(1):137-143. PubMed ID: 27595453
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular detection of type III secretory toxins in Pseudomonas aeruginosa isolates.
    Jarjees KK
    Cell Mol Biol (Noisy-le-grand); 2020 Jul; 66(5):9-14. PubMed ID: 33040805
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An outbreak of fluoroquinolone-resistant Pseudomonas aeruginosa ST357 harboring the exoU gene.
    Kainuma A; Momiyama K; Kimura T; Akiyama K; Inoue K; Naito Y; Kinoshita M; Shimizu M; Kato H; Shime N; Fujita N; Sawa T
    J Infect Chemother; 2018 Aug; 24(8):615-622. PubMed ID: 29628388
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dissemination in distinct Brazilian regions of an epidemic carbapenem-resistant Pseudomonas aeruginosa producing SPM metallo-beta-lactamase.
    Gales AC; Menezes LC; Silbert S; Sader HS
    J Antimicrob Chemother; 2003 Oct; 52(4):699-702. PubMed ID: 12951331
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bacteraemia due to extensively drug-resistant Pseudomonas aeruginosa sequence type 235 high-risk clone: Facing the perfect storm.
    Recio R; Villa J; Viedma E; Orellana MÁ; Lora-Tamayo J; Chaves F
    Int J Antimicrob Agents; 2018 Aug; 52(2):172-179. PubMed ID: 29621591
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High mortality of bloodstream infection outbreak caused by carbapenem-resistant P. aeruginosa producing SPM-1 in a bone marrow transplant unit.
    Chaves L; Tomich LM; Salomão M; Leite GC; Ramos J; Martins RR; Rizek C; Neves P; Batista MV; Amigo U; Guimaraes T; Levin AS; Costa SF
    J Med Microbiol; 2017 Dec; 66(12):1722-1729. PubMed ID: 29095142
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exoenzyme Y Contributes to End-Organ Dysfunction Caused by
    Wagener BM; Anjum N; Christiaans SC; Banks ME; Parker JC; Threet AT; Walker RR; Isbell KD; Moser SA; Stevens T; Alexeyev MF; Audia JP; Richter W; Hardy KS; Saleh LA; Morgan C; Pittet JF
    Toxins (Basel); 2020 Jun; 12(6):. PubMed ID: 32512716
    [No Abstract]   [Full Text] [Related]  

  • 28. Risk factors for healthcare-associated infection caused by carbapenem-resistant Pseudomonas aeruginosa.
    Tsao LH; Hsin CY; Liu HY; Chuang HC; Chen LY; Lee YJ
    J Microbiol Immunol Infect; 2018 Jun; 51(3):359-366. PubMed ID: 28988663
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changing the epidemiology of carbapenem-resistant Pseudomonas aeruginosa in a Brazilian teaching hospital: the replacement of São Paulo metallo-β-lactamase-producing isolates.
    Cavalcanti FL; Almeida AC; Vilela MA; Morais MM; Morais Junior MA
    Mem Inst Oswaldo Cruz; 2012 May; 107(3):420-3. PubMed ID: 22510840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk factors for mortality in patients with bloodstream infections caused by carbapenem-resistant Pseudomonas aeruginosa: clinical impact of bacterial virulence and strains on outcome.
    Jeong SJ; Yoon SS; Bae IK; Jeong SH; Kim JM; Lee K
    Diagn Microbiol Infect Dis; 2014 Oct; 80(2):130-5. PubMed ID: 25112900
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phenotypic and Molecular Survey of Metallo-beta-lactamase-producing
    Rouhi S; Ramazanzadeh R
    Infect Disord Drug Targets; 2020; 20(1):56-64. PubMed ID: 30659550
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urinary tract infections caused by Pseudomonas aeruginosa among children in Southern Poland: Virulence factors and antibiotic resistance.
    Pobiega M; Maciag J; Pomorska-Wesolowska M; Chmielarczyk A; Romaniszyn D; Ziolkowski G; Heczko PB; Wojkowska-Mach J; Bulanda M
    J Pediatr Urol; 2016 Feb; 12(1):36.e1-6. PubMed ID: 26320394
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of carbapenem resistance mechanisms and integrons in Pseudomonas aeruginosa strains from blood samples in a French hospital.
    Rojo-Bezares B; Cavalié L; Dubois D; Oswald E; Torres C; Sáenz Y
    J Med Microbiol; 2016 Apr; 65(4):311-319. PubMed ID: 26838942
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prevalence of cytotoxicity effectors in nosocomial Pseudomonas Aeruginosa strains].
    Kuznetsova MV; Maksimova AV; Karpunina TI; Demakov VA
    Zh Mikrobiol Epidemiol Immunobiol; 2014; (6):9-14. PubMed ID: 25816507
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidemiological characteristics and antimicrobial susceptibility among carbapenem-resistant non-fermenting bacteria in Brazil.
    Dias VC; Diniz CG; Peter AC; Bastos AN; Bastos VQ; Bastos LQ; Da Silva VL
    J Infect Dev Ctries; 2016 Jun; 10(6):544-53. PubMed ID: 27367001
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carbapenem-resistant Pseudomonas aeruginosa: association with virulence genes and biofilm formation.
    Rossi Gonçalves I; Dantas RCC; Ferreira ML; Batistão DWDF; Gontijo-Filho PP; Ribas RM
    Braz J Microbiol; 2017; 48(2):211-217. PubMed ID: 28034598
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Weighting the impact of virulence on the outcome of Pseudomonas aeruginosa bloodstream infections.
    Sánchez-Diener I; Zamorano L; Peña C; Ocampo-Sosa A; Cabot G; Gómez-Zorrilla S; Almirante B; Aguilar M; Granados A; Calbo E; Rodriguez-Baño J; Rodríguez-López F; Tubau F; Martínez-Martínez L; Navas A; Oliver A
    Clin Microbiol Infect; 2020 Mar; 26(3):351-357. PubMed ID: 31288102
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The influence of metallo-beta-lactamase production on mortality in nosocomial Pseudomonas aeruginosa infections.
    Zavascki AP; Barth AL; Gonçalves AL; Moro AL; Fernandes JF; Martins AF; Ramos F; Goldani LZ
    J Antimicrob Chemother; 2006 Aug; 58(2):387-92. PubMed ID: 16751638
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characteristics of carbapenem-resistant Pseudomonas aeruginosa strains in patients with ventilator-associated pneumonia in intensive care units.
    Vitkauskienė A; Skrodenienė E; Dambrauskienė A; Bakšytė G; Macas A; Sakalauskas R
    Medicina (Kaunas); 2011; 47(12):652-6. PubMed ID: 22370463
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular analysis of carbapenem-resistant strains of Pseudomonas aeruginosa isolated from patients hospitalized in various transplantation wards between 2008 and 2011.
    Kosykowska E; Szymanek-Majchrzak K; Walter de Walthoffen S; Izdebski R; Mlynarczyk A; Ciszek M; Chmura A; Durlik M; Paczek L; Deborska-Materkowska D; Sawicka-Grzelak A; Mlynarczyk G
    Transplant Proc; 2014 Oct; 46(8):2576-8. PubMed ID: 25380869
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.